Development of a New Method for Liver Stiffness Measurement Using FibroScan

Recruiting now · Not applicable

Conditions studied: Liver Diseases

In brief

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 153 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.

Key facts

Study ID

NCT06519331

Run by

Echosens

People needed

153

Starts

2024-11-08

Expected to finish

2027-12-01

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
• Adult patient able to give his written consent
• Patient affiliated to the French Social Security system

You may not qualify if…

• Vulnerable patients
• Patients with liver ascites
• Patients with heart failure

Where it is running

• Groupe Hospitalier Nord Essonne - Site Paris- Saclay — Orsay, France (enrolling)
• Hôpital Pitié-Salpêtrière — Paris, Île-de-France Region, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.